Altogether, these data suggest that CB2 stimulation with sub-micromolar doses of the agonist lead to the activation of PI3K/AKT signaling axis, and to the increase in tumor cell proliferation and aggressiveness. This evidence concerns the gene AKT1 and neoplasm.